| Product Code: ETC7916225 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market - Industry Life Cycle |
3.4 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market - Porter's Five Forces |
3.5 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of NTRK fusion gene positive advanced solid tumors in Latvia |
4.2.2 Advancements in precision medicine and targeted therapies for treating NTRK fusion gene positive tumors |
4.2.3 Rising awareness among healthcare professionals and patients about the importance of genetic testing for personalized treatment |
4.3 Market Restraints |
4.3.1 Limited availability and high cost of targeted therapies for NTRK fusion gene positive tumors |
4.3.2 Regulatory challenges in approving and accessing innovative treatments in Latvia |
5 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Trends |
6 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Types |
6.1 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.4 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.2.3 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Cancer Centers, 2021- 2031F |
6.2.4 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Import-Export Trade Statistics |
7.1 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Export to Major Countries |
7.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Imports from Major Countries |
8 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Key Performance Indicators |
8.1 Number of clinical trials focused on NTRK fusion gene positive tumors in Latvia |
8.2 Adoption rate of genetic testing for NTRK fusion gene in advanced solid tumors |
8.3 Rate of patient referrals to specialized centers for NTRK fusion gene positive tumor treatment |
9 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market - Opportunity Assessment |
9.1 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market - Competitive Landscape |
10.1 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenue Share, By Companies, 2024 |
10.2 Latvia NTRK Fusion Gene Positive Advanced Solid Tumor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here